136 related articles for article (PubMed ID: 15886500)
1. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.
Ito Y; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Oncology; 2005; 68(2-3):87-96. PubMed ID: 15886500
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
4. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.
Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2004 May; 28(5):498-501. PubMed ID: 15085396
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
Barić A; Marković V; Eterović D; Bedeković V; Kontić M; Juretić Kuščić L; Pešutić Pisac V; Punda A
Acta Clin Croat; 2017 Mar; 56(1):15-20. PubMed ID: 29120119
[TBL] [Abstract][Full Text] [Related]
7. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.
Timler D; Tazbir J; Matejkowska M; Gosek A; Czyz W; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():201-2. PubMed ID: 11820608
[TBL] [Abstract][Full Text] [Related]
8. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
11. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.
Lamba Saini M; Bouzin C; Weynand B; Marbaix E
PLoS One; 2016; 11(2):e0148656. PubMed ID: 26863116
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
13. Papillary microcarcinoma of the thyroid: how should it be treated?
Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2004 Nov; 28(11):1115-21. PubMed ID: 15490053
[TBL] [Abstract][Full Text] [Related]
14. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
Jarnagin WR; Klimstra DS; Hezel M; Gonen M; Fong Y; Roggin K; Cymes K; DeMatteo RP; D'Angelica M; Blumgart LH; Singh B
J Clin Oncol; 2006 Mar; 24(7):1152-60. PubMed ID: 16505435
[TBL] [Abstract][Full Text] [Related]
15. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
[TBL] [Abstract][Full Text] [Related]
16. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid.
Min HS; Choe G; Kim SW; Park YJ; Park DJ; Youn YK; Park SH; Cho BY; Park SY
Mod Pathol; 2008 Jun; 21(6):748-55. PubMed ID: 18360353
[TBL] [Abstract][Full Text] [Related]
17. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography.
Ito Y; Hirokawa M; Fukushima M; Inoue H; Yabuta T; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
World J Surg; 2008 Sep; 32(9):1955-60. PubMed ID: 18594906
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
19. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]